达美康(Gliclazide)系第二代磺酰脲类口服降血糖药。非糖尿病人误服致低血糖昏迷未见文献报告。现报告我院近期抢救成功一例。 患者 男,84岁。于1992年2月18日9、14和21时误服达美康3次,每次3片,总量720mg。24时觉双下肢麻木无力。次晨不能行走。无头痛、呕吐。正常进食。下午进晚餐时,感心慌、手抖、出汗。18时家人发现患者大汗,四肢及面部肌肉抽搐,持续约5min,随后意识丧失、呼之不应、鼾声大起,遂送我院。既往无 Gliclazide is the second generation of sulfonylurea oral hypoglycemic agents. Non-diabetic patients with hypoglycemic coma have not been reported in the literature. A report of successful rescue recently reported in our hospital. Male patient, 84 years old. On February 18, 1992, at 9, 14 and 21 orally mistakenly reached 3 times, 3 tablets, a total of 720mg. 24 when the feeling of numbness lower limbs. The next morning can not walk. No headache, vomiting. Normal eating. Afternoon into dinner, feel flustered, shaking hands, sweating. 18 when the family found that patients sweating, limbs and facial muscles convulsions, lasted about 5min, followed by loss of consciousness, call should not, snoring loudly, then sent to our hospital. No previous